iGMDRD56
Canonical SMILES: C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N
InChI: InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
InChI Key: NMUSYJAQQFHJEW-KVTDHHQDSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Standard NameAzacitidine CHEMBLCHEMBL1489 Pubchem CID9444 KEGG Drug IDD03021 DRUGBANK IDDB00928 Drug StatusAlone Drug targets (TTD)DAP000640 Drug TypeSmall Molecule |
Drug Class:
AntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsAza CompoundsCarbohydratesCytidineEnzyme InhibitorsGlycosidesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunosuppressive AgentsMyelosuppressive AgentsNoxaeNucleic Acids, Nucleotides, and NucleosidesNucleoside Metabolic InhibitorNucleosidesPyrimidine AnaloguesPyrimidine NucleosidesPyrimidinesRibonucleosidesToxic ActionsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Azacitidine
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |